lomerizine and cysteine

lomerizine has been researched along with cysteine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoyagi, J; Ebina, J; Hanashiro, S; Ikeda, K; Ishikawa, Y; Iwasaki, Y; Kawabe, K; Kyuzen, M; Miura, K; Morioka, H; Murata, K; Nagasawa, J; Sawada, M; Takazawa, T; Yanagihashi, M1
Kuriyama, M; Mizuno, T; Mizuta, I; Shiga, Y; Shimoe, Y; Tachiyama, K1

Other Studies

2 other study(ies) available for lomerizine and cysteine

ArticleYear
Preventive Treatment with Lomerizine Increases Cerebral Blood Flows during the Interictal Phase of Migraine.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:4

    Topics: Adult; Aged; Blood Flow Velocity; Calcium Channel Blockers; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Organotechnetium Compounds; Perfusion Imaging; Piperazines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2018
[CADASIL with cysteine-sparing NOTCH3 mutation manifesting as dissociated progression between cognitive impairment and brain image findings in 3 years: A case report].
    Rinsho shinkeigaku = Clinical neurology, 2018, Apr-25, Volume: 58, Issue:4

    Topics: Atrophy; Brain; CADASIL; Cerebrovascular Circulation; Cognition; Cognitive Dysfunction; Cysteine; Disease Progression; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Piperazines; Receptor, Notch3; Time Factors

2018